Recurrent coamplification of cytoskeleton-associated genes EMS1 and SHANK2 with CCND1 in oral squamous cell carcinoma

被引:59
作者
Freier, K
Sticht, C
Hofele, C
Flechtenmacher, C
Stange, D
Puccio, L
Toedt, G
Radlwimmer, B
Lichter, P
Joos, S
机构
[1] Deutsch Krebsforschungszentrum, Abt Mol Genet B060, D-69120 Heidelberg, Germany
[2] Univ Klinikum Heidelberg, Klin Mund Kiefer Gesichtschirurg, Heidelberg, Germany
[3] Univ Klinikum Heidelberg, Inst Pathol, Heidelberg, Germany
关键词
D O I
10.1002/gcc.20270
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Chromosomal band 11q13 is frequently amplified in oral squamous cell carcinoma (OSCC) and assumed to be critically involved in tumor initiation and progression by proto-oncogene activation. Though cyclin D1 (CCND1) is supposed to be the most relevant oncogene, several additional putative candidate genes are inside this chromosomal region, for which their actual role in tumorigenesis still needs to be elucidated. To characterize the 11q13 amplicon in detail, 40 OSCCs were analyzed by comparative genomic hybridization to DNA microarrays (matrix-CGH) containing BAC clones derived from chromosomal band 11q13. This high-resolution approach revealed a consistent amplicon about 1.7 Mb in size including the CCND1 oncogene. Seven BAC clones covering FGF3, EMS1, and SHANK2 were shown to be frequently coamplified inside the CCND1 amplicon. Subsequent analysis of tissue microarrays; by FISH revealed amplification frequencies of 36.8% (88/239) for CCND1, 34.3% (60/ 175) for FGF3, 37.4% (68/182) for EMS1, and 36.3% (61/168) for SHANK2. Finally, quantitative mRNA expression analysis demonstrated consistent overexpression of CCND1 in all tumors and of EMS1 and SHANK2 in a subset of specimens with 11q13 amplification, but no expression of FGF3 in any of the cases. Our study underlines the critical role of CCND1 in OSCC development and additionally points to the functionally related genes EMS1 and SHANK2, both encoding for cytoskeleton-associated proteins, which are frequently coamplified with CCND1 and therefore could cooperatively contribute to OSCC pathogenesis. (c) 2005 Wiley-Liss, Inc.
引用
收藏
页码:118 / 125
页数:8
相关论文
共 38 条
[1]  
Åkervall J, 2002, INT J ONCOL, V20, P45
[2]  
Akervall JA, 1997, CANCER, V79, P380
[3]   Quantitative mapping of amplicon structure by array CGH identifies CYP24 as a candidate oncogene [J].
Albertson, DG ;
Ylstra, B ;
Segraves, R ;
Collins, C ;
Dairkee, SH ;
Kowbel, D ;
Kuo, WL ;
Gray, JW ;
Pinkel, D .
NATURE GENETICS, 2000, 25 (02) :144-146
[4]   Prognostic value of genomic alterations in head and neck squamous cell carcinoma detected by comparative genomic hybridisation [J].
Ashman, JNE ;
Patmore, HS ;
Condon, LT ;
Cawkwell, L ;
Stafford, ND ;
Greenman, J .
BRITISH JOURNAL OF CANCER, 2003, 89 (05) :864-869
[5]   Prognostic value of CCND1 gene status in sporadic breast tumours, as determined by real-time quantitative PCR assays [J].
Bièche, I ;
Olivi, M ;
Noguès, C ;
Vidaud, M ;
Lidereau, R .
BRITISH JOURNAL OF CANCER, 2002, 86 (04) :580-586
[6]   Genetic imbalances with impact on survival in head and neck cancer patients [J].
Bockmühl, U ;
Schlüns, K ;
Küchler, I ;
Petersen, S ;
Petersen, I .
AMERICAN JOURNAL OF PATHOLOGY, 2000, 157 (02) :369-375
[7]   ProSAP/Shank proteins - a family of higher order organizing molecules of the postsynaptic density with an emerging role in human neurological disease [J].
Boeckers, TM ;
Bockmann, J ;
Kreutz, MR ;
Gundelfinger, ED .
JOURNAL OF NEUROCHEMISTRY, 2002, 81 (05) :903-910
[8]  
Casiglia Jeffrey, 2001, General Dentistry, V49, P72
[9]   POTENTIAL ONCOGENE PRODUCT RELATED TO GROWTH-FACTORS [J].
DICKSON, C ;
PETERS, G .
NATURE, 1987, 326 (6116) :833-833
[10]   Identification of a novel cortactin SH3 domain-binding protein and its localization to growth cones of cultured neurons [J].
Du, YR ;
Weed, SA ;
Xiong, WC ;
Marshall, TD ;
Parsons, JT .
MOLECULAR AND CELLULAR BIOLOGY, 1998, 18 (10) :5838-5851